HomeEQL • STO
add
EQL Pharma AB
Previous close
kr 59.10
Day range
kr 58.30 - kr 60.70
Year range
kr 57.10 - kr 108.80
Market cap
1.79B SEK
Avg Volume
59.80K
P/E ratio
42.02
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 107.22M | 29.50% |
Operating expense | 25.69M | 18.13% |
Net income | 9.83M | -5.60% |
Net profit margin | 9.17 | -27.11% |
Earnings per share | 0.33 | -20.60% |
EBITDA | 22.54M | 34.31% |
Effective tax rate | 20.64% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 56.11M | 319.61% |
Total assets | 797.28M | 96.09% |
Total liabilities | 566.41M | 159.28% |
Total equity | 230.87M | — |
Shares outstanding | 29.06M | — |
Price to book | 7.44 | — |
Return on assets | 6.37% | — |
Return on capital | 7.53% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 9.83M | -5.60% |
Cash from operations | -3.20M | 83.79% |
Cash from investing | -28.96M | -276.58% |
Cash from financing | 5.87M | -71.16% |
Net change in cash | -26.29M | -270.49% |
Free cash flow | -38.02M | -14.08% |
About
Founded
2006
Website
Employees
20
